Search company, investor...

Predict your next investment

University Health Network company logo
Corporation
uhn.ca

Investments

2

Portfolio Exits

4

Partners & Customers

10

About University Health Network

University Health Network is a hospital system.

Headquarters Location

R. Fraser Elliott Building 1st Floor 190 Elizabeth St.

Toronto, Ontario, M5G 2C4,

Canada

Want to inform investors similar to University Health Network about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest University Health Network News

TIAP & Amgen Co-funds transformative projects to support new venture development

Sep 20, 2023

TIAP announces co-funding of transformative projects with Amgen to support new venture development Toronto Innovation Acceleration Partners (TIAP) is excited to announce co-investments made with a key strategic partner, Amgen Inc., into three translational life sciences projects from its members: University of Toronto, University Health Network (UHN) and The Hospital for Sick Children (SickKids). The TIAP-Amgen partnership, formalized in 2019, has an objective to jointly fund nascent technologies managed by TIAP on behalf of its Toronto-based member institutions. The two organizations collaborate in a proactive manner to identify disruptive technologies derived from transformational discovery research conducted by the scientific community of Toronto. TIAP has reviewed dozens of projects from its membership and together with the partnership’s joint steering committee has identified three projects – two therapeutic projects and one platform validation project – for further investment. For the Toronto-based academic research community, the partnership enables early engagement and mentorship by corporate drug discovery experts and opportunities for follow-on support and company creation. The first slate of partnered projects, now underway, represents over $1 million in direct investment. In addition to the capital provided by TIAP and Amgen, each project has dedicated scientific and business expertise from Amgen and TIAP to ensure projects are hitting milestones and have appropriate expertise to support development and ultimately availability and distribution. The first approved project is in partnership with Dr. Robert Rottapel, Senior Scientist at the Princess Margaret Cancer Centre at UHN. The project is focused on developing monoclonal antibodies against a novel target for the treatment of drug-resistant ovarian cancers. In addition, this project has also secured financial support from UHN’s Princess Margaret Cancer Centre Innovation Acceleration Fund (IAF). Next is a therapeutic approach in the cardiovascular space, led by co-principal investigators Drs. John Coles and Jason Maynes from SickKids. This drug discovery effort, conducted in collaboration with Evotec through the LAB150 program, is aimed at developing a first-in-class molecule with envisioned applications in heart failure and cardiac fibrosis. Finally, the most recently approved project is a collaborative effort between Amgen’s Expression and Cell Engineering group and the laboratory of Dr. Shana Kelley, Professor at the University of Toronto. The project leverages the proprietary Microfluidics Immunomagnetic Cell Sorting Device developed by Dr. Kelley’s laboratory, with the aim of substantially boosting the yields of cell-grown biologic products. Said Parimal Nathwani, President and CEO of TIAP, “It is hugely significant for TIAP and the local health sciences community to work with an important partner such as Amgen. This partnership has already proven its merit by identifying and funding projects in less than a year in areas with large unmet medical needs and by supporting their accelerated progress and funding. With Amgen’s strong engagement, these projects are well positioned to advance through the critical early stages of development and move towards a path for venture creation” According to Phil Tagari, Vice President of Research at Amgen, “TIAP provides a unique and highly curated vehicle for Amgen’s scientists to access and support cutting-edge biomedical research in one of the world’s foremost centers of innovation and excellence. TIAP very efficiently enabled the identification and funding of the first three opportunities which span diverse areas of interest to Amgen Inc.” For more information, please contact Susanne Staer at sstaer@tiap.ca.

University Health Network Investments

2 Investments

University Health Network has made 2 investments. Their latest investment was in SQI Diagnostics as part of their Grant on March 3, 2020.

CBI Logo

University Health Network Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/25/2020

Grant

SQI Diagnostics

Yes

1

10/11/2011

Seed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

3/25/2020

10/11/2011

Round

Grant

Seed VC

Company

SQI Diagnostics

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

0

University Health Network Portfolio Exits

4 Portfolio Exits

University Health Network has 4 portfolio exits. Their latest portfolio exit was Adela on January 01, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/1/2020

Spinoff / Spinout

Adela

$99M

1

8/8/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

11/16/2016

Spinoff / Spinout

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2015

Spinoff / Spinout

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/1/2020

8/8/2019

11/16/2016

1/1/2015

Exit

Spinoff / Spinout

Acquired

Spinoff / Spinout

Spinoff / Spinout

Companies

Adela

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

University Health Network Acquisitions

1 Acquisition

University Health Network acquired 1 company. Their latest acquisition was Surgery Center of Columbia County on January 28, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/28/2020

$99M

Corporate Majority

1

Date

1/28/2020

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Corporate Majority

Sources

1

University Health Network Partners & Customers

10 Partners and customers

University Health Network has 10 strategic partners and customers. University Health Network recently partnered with Providence Therapeutics on June 6, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

6/2/2023

Partner

Canada

Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

Brad Wouters , Executive Vice President , Science and Research at the University Health Network added , `` Our partnership with Providence Therapeutics demonstrates the strength of discovery research at the University Health Network and our potential to fuel innovative therapeutic options for patients .

5

2/24/2023

Partner

Canada, and

Toronto Public Health, Unity Health Toronto and the University Health Network strike bold partnerships to address the drug poisoning crisis – City of Toronto

We are so pleased to announce this historic partnership between Toronto Public Health , Unity Health Toronto and University Health Network , with all of us working together in response to the ongoing drug poisoning crisis . ''

1

1/12/2023

Client, and Vendor

Canada

The Ottawa Hospital and Princess Margaret Cancer Centre partner with Gray Oncology Solutions to tackle important operational challenges in radiation oncology - EAHN

`` As one of our four projects with OBIO , the partnership with Gray Oncology Solutions Inc. is an opportunity to use innovation to help elevate and streamline how we deliver care to our patients . ''

1

12/7/2022

Vendor

Canada

Subscribe to see more

Subscribe to see more

10

9/8/2022

Vendor

Canada

Subscribe to see more

Subscribe to see more

10

Date

6/2/2023

2/24/2023

1/12/2023

12/7/2022

9/8/2022

Type

Partner

Partner

Client, and Vendor

Vendor

Vendor

Business Partner

Country

Canada

Canada, and

Canada

Canada

Canada

News Snippet

Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

Brad Wouters , Executive Vice President , Science and Research at the University Health Network added , `` Our partnership with Providence Therapeutics demonstrates the strength of discovery research at the University Health Network and our potential to fuel innovative therapeutic options for patients .

Toronto Public Health, Unity Health Toronto and the University Health Network strike bold partnerships to address the drug poisoning crisis – City of Toronto

We are so pleased to announce this historic partnership between Toronto Public Health , Unity Health Toronto and University Health Network , with all of us working together in response to the ongoing drug poisoning crisis . ''

The Ottawa Hospital and Princess Margaret Cancer Centre partner with Gray Oncology Solutions to tackle important operational challenges in radiation oncology - EAHN

`` As one of our four projects with OBIO , the partnership with Gray Oncology Solutions Inc. is an opportunity to use innovation to help elevate and streamline how we deliver care to our patients . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

1

1

10

10

University Health Network Team

9 Team Members

University Health Network has 9 team members, including current Executive Vice President, Rebecca Repa.

Name

Work History

Title

Status

Rebecca Repa

Executive Vice President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Rebecca Repa

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Executive Vice President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.